Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2025 | 2 | -$0.98 | -$0.45 | -$0.65 |
Q2 2025 | 1 | -$0.58 | -$0.58 | -$0.58 |
Q3 2025 | 1 | -$0.52 | -$0.52 | -$0.52 |
Q4 2025 | 1 | -$0.65 | -$0.65 | -$0.65 |
Q1 2026 | 1 | -$0.61 | -$0.61 | -$0.61 |
Q2 2026 | 1 | -$0.59 | -$0.59 | -$0.59 |
Q3 2026 | 1 | -$0.61 | -$0.61 | -$0.61 |
Q4 2026 | 1 | -$1.35 | -$1.35 | -$1.35 |
Acelyrin, Inc. last posted its earnings results on Wednesday, November 13th, 2024. The company reported $-0.49 earnings per share for the quarter, topping analysts' consensus estimates of $-0.84 by $0.35. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Acelyrin, Inc. has generated $-5 earnings per share over the last year ($-5.43 diluted earnings per share) and currently has a price-to-earnings ratio of -1.04. Acelyrin, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 27th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/13/2024 | Q3 2024 | -$0.84 | -$0.49 | 0.35 | $0 | $0 |
08/13/2024 | Q2 2024 | -$0.66 | -$0.86 | -0.2 | $0 | $0 |
05/14/2024 | Q1 2024 | -$0.93 | -$0.36 | 0.57 | N/A | $0 |
03/28/2024 | Q4 2023 | -$1.00 | -$0.98 | 0.02 | N/A | $166,000 |
11/09/2023 | Q3 2023 | N/A | -$0.87 | N/A | N/A | $0 |
08/14/2023 | Q2 2023 | -$0.81 | -$0.40 | 0.41 | N/A | $0 |
06/15/2023 | Q1 2023 | -$10.89 | -$1.82 | 9.07 | N/A | $0 |
12/30/2022 | Q4 2022 | N/A | -$10.44 | N/A | N/A | $0 |
09/29/2022 | Q3 2022 | N/A | -$0.70 | N/A | N/A | $0 |
06/29/2022 | Q2 2022 | N/A | -$0.71 | N/A | N/A | $0 |
03/30/2022 | Q1 2022 | N/A | -$0.79 | N/A | N/A | $0 |
Acelyrin, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 27th, 2025 based offlast year's report dates.
In the previous quarter, Acelyrin, Inc. (:SLRN) reported $-0.49 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.84 by $0.35.
The conference call for Acelyrin, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Acelyrin, Inc.'s latest earnings report can be read online.
Acelyrin, Inc. (:SLRN) has a recorded net income of $-381,641,000.Acelyrin, Inc. has generated $-5.43 earnings per share over the last four quarters.
Acelyrin, Inc. (:SLRN) has a price-to-earnings ratio of -1.04 and price/earnings-to-growth ratio is -0.08.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED